Research platforms
Behind every breakthrough is the right tool in the right hands. Our research platforms place world-class technology at the heart of our science — empowering our scientists to ask deeper questions, move faster, and translate discoveries into real health outcomes for people living with cardiovascular disease, diabetes and obesity.
From advanced imaging and proteomics to mRNA therapeutics and single-cell analysis, our platforms span the full breadth of modern biomedical research.
9.4T MRI
The 9.4T animal magnetic resonance imaging system is optimised for high-resolution sample imaging.
Baker Specialist Clinics
Reducing death and disability from cardiovascular disease, diabetes and related conditions through research, education and health care delivery.
Biomarker Discovery Platform
Providing important infrastructure for the detection and quantification of biomarkers, such as proteins, peptides and nucleotides, in any biological fluids and samples.
CRISPR Validation Platform
Harnessing RNA therapeutics and LNP technologies to facilitate CRISPR gene editing in preclinical models.
EpiMed Centre
Advancing epigenomic medicine by investigating how functional foods, natural compounds and lifestyle behaviours influence wellbeing.
Magnetic Particle Imaging
Magnetic Particle Imaging (MPI) is a new non-invasive imaging method that detects iron oxide nanoparticles to produce 2D and 3D images. MPI imaging is more sensitive and significantly faster than MRI and PET imaging.
Metabolomic Profiling Facility
Using state-of-the-art tandem mass spectrometry to obtain metabolic profiles (primarily lipids) from cell and animal models.
Microscopy Centre
Enabling researchers to perform leading-edge microscopy to advance the treatment of cardiovascular disease, diabetes, and related disorders.
Cardiometabolic mRNA therapy
Harnessing the transformative power of mRNA-based therapies to address the global burden of cardiometabolic diseases.
PET-CT
The Mediso NanoPET/CT is a small animal preclinical scanner suitable for a wide variety of radioactive tracer imaging and computer tomography (CT).
Proteomics Research Platform
Developing and applying advanced proteomics methods to further our understanding of cardiac disease, pathways, targets, and drug effects.
Single-Cell Omics Platform
The Single-Cell Omics Platform applies single-cell omic approaches to understand complex tissues in context of development and disease.
Translational Cardiology Centre
Leaders in clinical assessments of animal models for trials of new medicines.
There's a way to give that's right for you
Whether you make a one-off gift, give regularly or leave a lasting legacy, your support helps us keep doing research that saves lives.